التفاصيل البيبلوغرافية
| العنوان: |
Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis. |
| المؤلفون: |
Dong, Mei, Yang, Yunlong, Hosaka, Kayoko, Zhang, Yun, Zhao, Yuxia |
| المصدر: |
Frontiers in Endocrinology; 2025, p1-3, 3p |
| مصطلحات موضوعية: |
LIPOPROTEIN lipase, HDL cholesterol, ANGIOPOIETIN-like proteins, LOW density lipoproteins, HEART metabolism disorders, NIACIN, CHYLOMICRONS, CHOLESTERYL ester transfer protein, MUSCLE mass |
| مستخلص: |
The editorial in Frontiers in Endocrinology discusses triglycerides-rich lipoproteins (TRL) as a new target for atherosclerosis, particularly in diabetic populations. The accumulation of TRLs and their cholesterol-enriched remnants is linked to atherogenesis, with Apo CIII and ANGPTL3 identified as key targets for therapeutic strategies. Various studies highlight the importance of understanding TRL metabolism and residual cholesterol in relation to metabolic disorders and cardiovascular diseases, suggesting potential new clinical monitoring indicators and risk assessment tools. Research focuses on developing novel drugs to reduce TRLs and improve patient prognosis, emphasizing the need for standardized residue detection methods in clinical practice. [Extracted from the article] |
|
Copyright of Frontiers in Endocrinology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder